Legal & General Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.64B | Buy |
12,159,427
+26,096
| +0.2% | +$5.79M | 0.61% | 20 |
|
|
2025
Q4 | $2.77B | Buy |
12,133,331
+129,247
| +1% | +$29.4M | 0.61% | 17 |
|
|
2025
Q3 | $2.78B | Buy |
12,004,084
+493,420
| +4% | +$100M | 0.62% | 19 |
|
|
2025
Q2 | $2.14B | Sell |
11,510,664
-171,264
| -1% | -$31.8M | 0.53% | 23 |
|
|
2025
Q1 | $2.45B | Buy |
11,681,928
+97,315
| +0.8% | +$18.9M | 0.67% | 20 |
|
|
2024
Q4 | $2.06B | Sell |
11,584,613
-439,714
| -4% | -$80.8M | 0.54% | 25 |
|
|
2024
Q3 | $2.37B | Buy |
12,024,327
+171,290
| +1% | +$32M | 0.62% | 21 |
|
|
2024
Q2 | $2.03B | Sell |
11,853,037
-348,841
| -3% | -$57.8M | 0.57% | 22 |
|
|
2024
Q1 | $2.22B | Sell |
12,201,878
-81,472
| -0.7% | -$14M | 0.64% | 21 |
|
|
2023
Q4 | $1.9B | Buy |
12,283,350
+188,816
| +2% | +$27.5M | 0.59% | 23 |
|
|
2023
Q3 | $1.8B | Sell |
12,094,534
-533,050
| -4% | -$78.3M | 0.63% | 23 |
|
|
2023
Q2 | $1.7B | Buy |
12,627,584
+741,031
| +6% | +$109M | 0.55% | 25 |
|
|
2023
Q1 | $1.89B | Buy |
11,886,553
+148,488
| +1% | +$22.7M | 0.68% | 21 |
|
|
2022
Q4 | $1.9B | Sell |
11,738,065
-533,001
| -4% | -$81.7M | 0.73% | 20 |
|
|
2022
Q3 | $1.65B | Sell |
12,271,066
-259,294
| -2% | -$37.2M | 0.64% | 24 |
|
|
2022
Q2 | $1.92B | Buy |
12,530,360
+476,257
| +4% | +$72.8M | 0.68% | 22 |
|
|
2022
Q1 | $1.95B | Buy |
12,054,103
+784,446
| +7% | +$114M | 0.59% | 20 |
|
|
2021
Q4 | $1.53B | Sell |
11,269,657
-373,125
| -3% | -$44.1M | 0.46% | 31 |
|
|
2021
Q3 | $1.26B | Buy |
11,642,782
+463,730
| +4% | +$53M | 0.41% | 43 |
|
|
2021
Q2 | $1.26B | Buy |
11,179,052
+193,109
| +2% | +$21.7M | 0.42% | 40 |
|
|
2021
Q1 | $1.19B | Sell |
10,985,943
-294,397
| -3% | -$31.5M | 0.44% | 38 |
|
|
2020
Q4 | $1.21B | Buy |
11,280,340
+451,897
| +4% | +$43.4M | 0.47% | 36 |
|
|
2020
Q3 | $948M | Sell |
10,828,443
-319,749
| -3% | -$30.1M | 0.42% | 45 |
|
|
2020
Q2 | $1.09B | Buy |
11,148,192
+1,755,024
| +19% | +$155M | 0.53% | 33 |
|
|
2020
Q1 | $716M | Buy |
9,393,168
+247,883
| +3% | +$21.1M | 0.42% | 46 |
|
|
2019
Q4 | $810M | Buy |
9,145,285
+185,411
| +2% | +$15.4M | 0.39% | 48 |
|
|
2019
Q3 | $678M | Buy |
8,959,874
+106,093
| +1% | +$7.27M | 0.36% | 50 |
|
|
2019
Q2 | $644M | Sell |
8,853,781
-119,553
| -1% | -$9.4M | 0.35% | 53 |
|
|
2019
Q1 | $723M | Buy |
8,973,334
+1,586,937
| +21% | +$130M | 0.41% | 45 |
|
|
2018
Q4 | $681M | Buy |
7,386,397
+490,348
| +7% | +$43.1M | 0.53% | 32 |
|
|
2018
Q3 | $652M | Sell |
6,896,049
-157,621
| -2% | -$14.9M | 0.47% | 37 |
|
|
2018
Q2 | $654M | Sell |
7,053,670
-548,337
| -7% | -$53.6M | 0.5% | 32 |
|
|
2018
Q1 | $720M | Sell |
7,602,007
-461,143
| -6% | -$50.7M | 0.55% | 32 |
|
|
2017
Q4 | $780M | Sell |
8,063,150
-54,690
| -0.7% | -$5.15M | 0.56% | 33 |
|
|
2017
Q3 | $721M | Buy |
8,117,840
+68,489
| +0.9% | +$5.21M | 0.54% | 32 |
|
|
2017
Q2 | $584M | Buy |
8,049,351
+131,159
| +2% | +$8.82M | 0.47% | 39 |
|
|
2017
Q1 | $516M | Buy |
7,918,192
+312,055
| +4% | +$19.6M | 0.44% | 40 |
|
|
2016
Q4 | $476M | Buy |
7,606,137
+85,046
| +1% | +$5.19M | 0.44% | 40 |
|
|
2016
Q3 | $474M | Buy |
7,521,091
+50,873
| +0.7% | +$3.29M | 0.48% | 40 |
|
|
2016
Q2 | $462M | Buy |
7,470,218
+272,165
| +4% | +$16.6M | 0.49% | 42 |
|
|
2016
Q1 | $411M | Sell |
7,198,053
-216,926
| -3% | -$12.1M | 0.46% | 41 |
|
|
2015
Q4 | $439M | Buy |
7,414,979
+60,181
| +0.8% | +$3.47M | 0.5% | 40 |
|
|
2015
Q3 | $400M | Buy |
7,354,798
+197,847
| +3% | +$12.9M | 0.49% | 39 |
|
|
2015
Q2 | $481M | Buy |
7,156,951
+587,045
| +9% | +$38.3M | 0.56% | 35 |
|
|
2015
Q1 | $385M | Sell |
6,569,906
-11,078
| -0.2% | -$669K | 0.46% | 45 |
|
|
2014
Q4 | $431M | Sell |
6,580,984
-216,511
| -3% | -$13.6M | 0.51% | 38 |
|
|
2014
Q3 | $393M | Sell |
6,797,495
-158,784
| -2% | -$8.82M | 0.47% | 42 |
|
|
2014
Q2 | $393M | Buy |
6,956,279
+103,865
| +2% | +$5.45M | 0.46% | 43 |
|
|
2014
Q1 | $352M | Sell |
6,852,414
-126,123
| -2% | -$6.37M | 0.43% | 49 |
|
|
2013
Q4 | $369M | Sell |
6,978,537
-30,618
| -0.4% | -$1.5M | 0.45% | 49 |
|
|
2013
Q3 | $314M | Sell |
7,009,155
-37,262
| -0.5% | -$1.65M | 0.41% | 54 |
|
|
2013
Q2 | $291M | Buy |
+7,046,417
| New | +$308M | 0.4% | 53 |
|
Other funds holding ABBV
VCM
VPM
Legal & General Group's ABBV Position: Q1 2026 in Review
Legal & General Group increased its AbbVie (ABBV) stake by 0.22% in Q1 2026, buying an estimated $5.79M and bringing the position to 12,159,427 shares worth $2.64B. The position accounts for 0.61% of the portfolio, ranked #20.
Legal & General Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.78B in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Legal & General Group held 12,159,427 shares of AbbVie worth $2.64B as of Q1 2026.
- Legal & General Group bought 26,096 AbbVie shares in Q1 2026, an estimated $5.79M.
- AbbVie made up 0.61% of Legal & General Group's portfolio in Q1 2026, its #20 holding.
- Legal & General Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Legal & General Group's AbbVie position peaked at $2.78B in Q3 2025.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.